|1.||Gibson, Peter R: 3 articles (09/2014 - 07/2012)|
|2.||Barrett, Jacqueline S: 3 articles (09/2014 - 07/2012)|
|3.||Theocharis, Achilleas D: 3 articles (09/2002 - 04/2002)|
|4.||Theocharis, Dimitrios A: 3 articles (09/2002 - 04/2002)|
|5.||Staudacher, H M: 2 articles (12/2015 - 10/2011)|
|6.||Whelan, K: 2 articles (12/2015 - 10/2011)|
|7.||Lomer, M C E: 2 articles (12/2015 - 10/2011)|
|8.||Irving, P M: 2 articles (12/2015 - 10/2011)|
|9.||Hecht, Sidney M: 2 articles (05/2015 - 11/2014)|
|10.||Rishel, Michael J: 2 articles (05/2015 - 11/2014)|
05/01/2004 - "Compared with placebo or no intervention, non-absorbable disaccharides seemed to reduce the risk of no improvement in patients with hepatic encephalopathy (relative risk 0.62, 95% confidence interval 0.46 to 0.84, six trials). "
02/01/2007 - "Non-absorbable disaccharides are first-line therapy for hepatic encephalopathy, but published clinical studies evaluating their safety and efficacy are limited. "
01/10/2005 - "[Nonabsorbable disaccharides for the treatment of hepatic encephalopathy--a systemic review of randomized clinical trials--a secondary publication]."
05/01/2004 - "Non-absorbable disaccharides should not serve as comparator in randomised trials on hepatic encephalopathy."
05/01/2004 - "Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials."
|2.||Dehydration (Water Stress)
07/05/2005 - "Dehydration damage of domain-exhibiting supported bilayers: an AFM study on the protective effects of disaccharides and other stabilizing substances."
03/01/2011 - "Investigation of disaccharides was stimulated by the variety of organisms that tolerate dehydration stress by accumulation of disaccharides. "
06/01/2008 - "Disaccharides are known to protect sensitive biomolecules against stresses caused by dehydration, both in vivo and in vitro. "
07/05/2005 - "These phenomena can be avoided if disaccharides are added during dehydration. "
03/01/2002 - "Plants and animals that can survive dehydration accumulate high concentrations of disaccharides in their cells and tissues during desiccation. "
01/01/2006 - "Recent studies have challenged the efficacy of nonabsorbable disaccharides and have reported that protein restriction may pose risks to patients with cirrhosis and hepatic encephalopathy. "
12/01/2014 - "The highest stimulatory activity was associated with fibrosis-affected fascia decorin DS, which is characterized by a particularly high content of 6-O-sulphated disaccharides. "
02/01/2010 - "Long-term feeding of a synthetic diet rich in disaccharides induces hepatic fibrosis in nonalcoholic fatty liver disease in Zucker rats."
06/06/2014 - "Thus, after the HE episode resolves, it is recommended: control and prevention of precipitating factors (gastrointestinal bleeding, spontaneous bacterial peritonitis, use of diuretics with caution, avoid nervous system depressant medications), continued administration of non-absorbable disaccharides such as lactulose or lactitol, few or non-absorbable antibiotics such as rifaximin and assess the need for a liver transplant as the presence of a HE episode carries a poor prognosis in cirrhosis. "
07/01/2013 - "Evidence of the association of the intake of mono and disaccharides with different types of cancer is insufficient or there is evidence of lack of association. "
01/01/2011 - "However, the activation of immune responses against terminal mono- and disaccharide constituents of TACA raises concerns regarding the balance between "tumor destruction" and "tissue damage", as mono- and disaccharides are also expressed on normal tissue. "
11/04/2014 - "Modified bleomycin disaccharides exhibiting improved tumor cell targeting."
12/28/2010 - "Disaccharides were identified that inhibited galectin-1 function and increased growth and activation of CD8(+) CTL's killing cancer cells. "
02/01/2008 - "A new series of indolocarbazole glycosides containing disaccharides were synthesized and their in vitro antiproliferative activity was evaluated against three human cancer cell lines (A2780, H460, and GLC4). "
|5.||Vascular Diseases (Vascular Disease)
|1.||rifaximin (L 105)
|7.||Anti-Bacterial Agents (Antibiotics)
|9.||Hyaluronic Acid (Hyaluronan)
|2.||Carbohydrate-Restricted Diet (Low Carbohydrate Diet)
|4.||Laser In Situ Keratomileusis (LASIK)